Skip to main content
. 2021 Jan 25;12:81. doi: 10.1186/s13287-020-02128-1

Fig. 1.

Fig. 1

CAR T cell engineering. The design of the CAR T cell has evolved by combining existing immune cell components to facilitate direct targeting of tumor antigens. scFv of CAR-induced light and heavy chains of the antibody variable region, whereas the CAR amplitude CD3ζ has been derived from the intracellular signaling domains of the TCR